Search results
Fred brings close to 30 years of biotech, pharmaceutical, and medical device experience to Alexion, where he oversees strategy and business development activities. Prior to joining Alexion, he served as president and chief executive officer of LogicBio. Previously, Fred served as the president and chief operating officer of aTyr Pharma Inc.
Experience: Alexion Pharmaceuticals, Inc. · Location: Boston · 500+ connections on LinkedIn. View Frederic "Fred" Chereau’s profile on LinkedIn, a professional community of 1 billion members.
- 500+
- Alexion Pharmaceuticals, Inc.
Frédéric Chéreau is a businessperson who has been at the helm of 7 different companies and holds the position of Chairman for Horama SA, Chief Executive Officer of MYOSIX SA and Chairman of Maisons &...
Frederic Chereau, CEO of LogicBio, will join Alexion as Senior Vice President, Strategy and Business Development. Additional Transaction Details The tender offer for all of the issued and outstanding shares of common stock of LogicBio expired as scheduled at one minute following 11:59 p.m.,
Paris, France, October 20 th, 2022 – Coave Therapeutics (‘Coave’), a biotech company leading the transition of genetic medicine from (ultra) rare to prevalent conditions in neurodegenerative diseases, today announces Frederic Chereau as Chairman of the Board and the appointment of Dr Claudia Mitchell, PhD, MBA to the Company’s Board of Directors as an independent non-executive director.
Oct 12, 2021 · Frederic Chereau MBA. Frederic currently serves as the President and Chief Executive Officer of LogicBio, a clinical stage genetic medicines company pioneering gene editing and delivery platforms ...
Frederic Chereau is the SVP, Strategy and Business Development at Alexion Pharmaceuticals. Additionally, Frederic Chereau has had 3 past jobs including President & CEO at LogicBio Therapeutics . Alexion Pharmaceuticals SVP, Strategy and Business Development Nov 2022
